Looking to publish in Cytotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.
Looking to publish in Cytotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cytotherapy accepts the following article types. Click on an article type to view submission instructions.
Full-Length Articles
Review Articles
Short Reports
Brevia
Letters To The Editors
Recent Publications
Large-particle T-cell activation improves manufacturability, reduces phagocytic loss, and enhances CAR-T cell cytotoxic function
Matic Bartol, Tina Fink, Tina Tragin, Ema Pleško, Roman Jerala, Hana Esih, Aljaž Kravanja, Brina Štante, Valentina Bianco, Luka Fajs, Mojca Jež
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 31 days from submission to decision after review; 91 days from submission to acceptance.
Reformat to Cytotherapy using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3500 excluding taxes for all article types. Subscription publication has no open access publication fee.
Reformat to Cytotherapy using Livewrite Premium